The paradox of immune checkpoint inhibition re-activating tuberculosis.

Authors:
Ahmed M; Tezera LB; Elkington PT; Leslie AJ.

Journal:
Eur Respir J

Publication Year: 2022

DOI:
10.1183/13993003.02512-2021

PMCID:
PMC9647068

PMID:
35595321

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Eur Respir J

Abbreviation: Eur Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of combined phenotypic ageing and genetic risk with incidence of chronic respiratory d…
Wang T; Duan W; Jia X and 4 more (2024) - Transparency Score: 3/6
CPAP resumption after a first termination and impact on all-cause mortality in France.
Pépin JL; Tamisier R; Benjafield AV and 9 more (2024) - Transparency Score: 3/6
Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, bu…
Kerem E; Orenti A; Adamoli A and 4 more (2024) - Transparency Score: 3/6
Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmo…
Houston CJ; Alkhatib A; Einarsson GG and 3 more (2024) - Transparency Score: 3/6
Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in auto…
Campo I; Carey BC; Paracchini E and 11 more (2024) - Transparency Score: 5/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: None declared."

Evidence found in paper:

"Support statement: This work was funded by a Wellcome Strategic Core Award (201433/A/16/A), a Wellcome Senior Research Fellowship (210662/Z/18/Z) and the Sub-Saharan African Network for TB/HIV Research Excellence. Funding information for this article has been deposited with the Crossref Funder Registry."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025